Ireland
--:--IST
Active, not recruiting Not applicable

Feasibility Study of the Pilot Post-primary Active School Flag (PPASF) Program

NCT03847831 · tracked via the Priya Life Science Ireland tracker
Phase
Not applicable
Started
2018-09-01
Last updated
2024-05-16

Condition(s) studied

Physical ActivityHealth BehaviorHealth Knowledge, Attitudes, PracticeEducational Problems

Investigational drug(s) / intervention(s)

Active School Flag Program

Active School Flag Program: Schools enrolled in the program take part in the 17 actions described in the PPASF.

Study summary

The Feasibility of the post-primary Active School Flag (PPASF) programme. The PPASF is an initative from the Department of Education and Skills in a whole-school program to increase physical activity opportunities involving the students in second level education schools in Ireland. Various actors involved in the process include admin, teachers, and students to create more physical activity opportunities for the students in the school. Process evaluation and fidelity of the program are carried out during the year long process for certificate and two years for achieving the flag. Results of this study will inform the design and implementation of the PPASF in a national roll out across Irish second level education schools.

Eligibility

Sex
ALL
Min age
12 Years
Max age
19 Years
Healthy volunteers
Accepted
Inclusion Criteria: * students and teachers in the enrolled schools Exclusion Criteria: * students and teachers not enrolled in the schools * students who did not provide consent or assent to take part in the study

Primary outcome measure(s)

  • Adherence to the PPASF programme's components in the schools — up to 9 months
    Customized fidelity check list based on the 17 program elements.

Trial sites (1)

FacilityCityRegionStatus
University of Limerick Limerick Ireland
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT03847831 on ClinicalTrials.gov ↗ ← All trials in Ireland